Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 4,175 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control comparison Clear all

Conditions: Driving Performance
Interventions: Rapastinel, Alprazolam, Ketamine, Rapastinel Matched Placebo, Alprazolam Matched Placebo, Ketamine Matched Placebo; Drug
Lead sponsor: Naurex, Inc, an affiliate of Allergan plc; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Clemente, California

Conditions: Non-alcoholic Steatohepatitis (NASH)
Interventions: Tropifexor (LJN452), Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 31
States / cities: Madison, Alabama • North Little Rock, Arkansas • Coronado, California + 28 more

Conditions: Alzheimer Disease
Interventions: BI 409306, Placebo; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 55 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 7
States / cities: Orange, California • Sherman Oaks, California • West Palm Beach, Florida + 4 more

Conditions: Autism Spectrum Disorder, Autism
Interventions: ASSIST; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • Nashville, Tennessee • Madison, Wisconsin

Conditions: Surgical Site Infection
Interventions: Chloraprep, 0.9% Physiological Saline, ZuraPrep without IPA; Drug · Other
Lead sponsor: Zurex Pharma, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Bozeman, Montana

Conditions: Healthy
Interventions: wheat bran extract, control wheat bran extract; Other
Lead sponsor: Kellogg Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Glen Ellyn, Illinois

Conditions: Proximal Interphalangeal Joint Stiffness
Interventions: RMO flexion orthosis (splint), Standard of care; Device · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Posttraumatic Stress Disorder (PTSD)
Interventions: Attention Bias Modification (ABM), Attention control training (ACT); Behavioral
Lead sponsor: Research Foundation for Mental Hygiene, Inc.; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcoholism
Interventions: Daily monitoring of alcohol & drug use, & therapy skills, control group; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 19 Years and older
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Plantar Fasciitis
Interventions: platelet rich plasma, corticosteroid injection; Biological · Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: San Bernadino, California

Conditions: Turner Syndrome
Interventions: Lonapegsomatropin, Somatropin; Biological · Drug
Lead sponsor: Ascendis Pharma Endocrinology Division A/S; Industry
Eligibility: 1 Year to 10 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 19
States / cities: Palo Alto, California • San Diego, California • Aurora, Colorado + 16 more

Conditions: Acne Vulgaris
Interventions: Adapalene and Benzoyl Peroxide Topical Gel, Epiduo Topical Product, Placebo; Drug
Lead sponsor: Padagis LLC; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 825 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Breast Cancer
Interventions: Video and Booklet, Factsheet; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Lung Cancer
Interventions: Engaged Approach to Lung Cancer Screening; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Gestational Diabetes
Interventions: Glyburide, Insulin; Drug
Lead sponsor: Tripler Army Medical Center; Federal
Eligibility: 18 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Type 1 Diabetes
Interventions: Closed-Loop, Model Predictive Control (MPC), Open-Loop; Device
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Wound Heal, Mouth; Wound, Periodontal Inflammation
Interventions: Emanate Tray; Device
Lead sponsor: Emanate Biomedical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare
Interventions: PL8177 Placebo, PL8177; Drug
Lead sponsor: Palatin Technologies, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 14
States / cities: Tucson, Arizona • Lancaster, California • Tarzana, California + 11 more

Conditions: Pre-eclampsia
Interventions: Anti-digoxin antibody (FAB fragment), sodium chloride; Drug · Other
Lead sponsor: BTG International Inc.; Other
Eligibility: Female only
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 8
States / cities: Mobile, Alabama • Phoenix, Arizona • Orlando, Florida + 5 more

Conditions: Cardiometabolic Syndrome
Interventions: Aegis CDM Test and Educational Materials; Diagnostic Test
Lead sponsor: Qure Healthcare, LLC; Industry
Eligibility: Not listed
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension, Obesity, Healthy Nutrition, Blood Pressure
Interventions: RN-CHeFRx; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Covid19
Interventions: Metformin, Naltrexone; Drug
Lead sponsor: AgelessRx; Industry
Eligibility: 30 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Treatment in Calcified Coronary Disease
Interventions: Intravascular Lithotripsy, Cutting Balloon; Device
Lead sponsor: Baim Institute for Clinical Research; Other
Eligibility: 21 Years and older
Enrollment: 413 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 22
States / cities: Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 17 more

Conditions: Erectile Dysfunction
Interventions: Levitra (Vardenafil, BAY38-9456), Sildenafil, Placebo; Drug
Lead sponsor: Bayer; Industry
Eligibility: 25 Years to 64 Years · Male only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 18
States / cities: Phoenix, Arizona • Tempe, Arizona • Beverly Hills, California + 15 more

Search by objective public record fields.

Assessment of Effect of Rapastinel on Driving Performance

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo

Advocating for Supports to Improve Service Transitions

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Study to Determine the Digestive and Physiological Effects of an Extract From Bran in Healthy Men and Women

Pilot Study on The Effectiveness of Relative Motion Orthosis in Finger Motion

Attention-Bias Modification Treatment for PTSD

Using Telephone Technology to Prevent Relapse After Alcoholism Treatment

Treatment of Plantar Fasciitis With Platelet Rich Plasma

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face

Genetic Counseling for Breast Cancer Survivors (GC for BC)

Testing the Engaged Approach to Lung Cancer Screening

Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes

Pilot Study of Closed-Loop Glucose Control in People With Type 1 Diabetes (BPK004)

Impact of Daily Use of The Emanate Tray Adjunct to Full Mouth Debridement Compared to Full Mouth Debridement Alone

Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)

Efficacy Study of Digibind for Treatment of Severe Preeclampsia

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial

Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function